729 related articles for article (PubMed ID: 25824125)
1. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
2. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.
Lacson E; Wang W; Ma L; Passlick-Deetjen J
Am J Kidney Dis; 2015 Dec; 66(6):1056-66. PubMed ID: 26190226
[TBL] [Abstract][Full Text] [Related]
3. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
Nishizawa Y; Shoji T; Kakiya R; Tsujimoto Y; Tabata T; Ishimura E; Nakatani T; Miki T; Inaba M
Kidney Int Suppl; 2003 May; (84):S117-20. PubMed ID: 12694324
[TBL] [Abstract][Full Text] [Related]
4. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of baseline adiponectin on all-cause mortality in hemodialysis patients depending on initial body mass index. Long-term follow-up data of 4.5 years.
Tsigalou C; Chalikias G; Kantartzi K; Tziakas D; Kampouromiti G; Vargemezis V; Konstantinides S; Ktenidou-Kartali S; Simopoulos K; Passadakis P
J Ren Nutr; 2013 Jan; 23(1):45-56. PubMed ID: 22406123
[TBL] [Abstract][Full Text] [Related]
6. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
[TBL] [Abstract][Full Text] [Related]
7. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients.
Chiang CK; Ho TI; Hsu SP; Peng YS; Pai MF; Yang SY; Hung KY; Tsai TJ
Blood Purif; 2005; 23(2):134-40. PubMed ID: 15665509
[TBL] [Abstract][Full Text] [Related]
9. Lean Body Mass and Survival in Hemodialysis Patients and the Roles of Race and Ethnicity.
Wang J; Streja E; Rhee CM; Soohoo M; Feng M; Brunelli SM; Kovesdy CP; Gillen D; Kalantar-Zadeh K; Chen JL
J Ren Nutr; 2016 Jan; 26(1):26-37. PubMed ID: 26482246
[TBL] [Abstract][Full Text] [Related]
10. Associations of adiponectin and leptin levels with protein-energy wasting, in end stage renal disease patients.
Markaki A; Grammatikopoulou MG; Venihaki M; Kyriazis J; Perakis K; Stylianou K
Endocrinol Nutr; 2016 Nov; 63(9):449-457. PubMed ID: 27638461
[TBL] [Abstract][Full Text] [Related]
11. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.
Kaysen GA; Kotanko P; Zhu F; Sarkar SR; Heymsfield SB; Kuhlmann MK; Dwyer T; Usvyat L; Havel P; Levin NW
J Ren Nutr; 2009 Sep; 19(5):357-64. PubMed ID: 19596588
[TBL] [Abstract][Full Text] [Related]
12. Are lipoprotein disturbances in chronic hemodialyzed patients only renal failure related?
Jakić M; Lovcić V; Klarić D; Mihaljević D; Zibar L; Jakić M; Marić I
Coll Antropol; 2010 Mar; 34 Suppl 1():181-8. PubMed ID: 20402316
[TBL] [Abstract][Full Text] [Related]
13. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
Refaat H; Sany D; Mohab A; Ezzat H
Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
[TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
El-Shafey EM; Shalan M
Ther Apher Dial; 2014 Apr; 18(2):185-92. PubMed ID: 24720410
[TBL] [Abstract][Full Text] [Related]
15. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
16. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis.
Nakagawa N; Matsuki M; Yao N; Hirayama T; Ishida H; Kikuchi K; Hasebe N
Ther Apher Dial; 2015 Feb; 19(1):30-9. PubMed ID: 25196142
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis.
Xia X; He F; Wu X; Peng F; Huang F; Yu X
Am J Kidney Dis; 2014 Aug; 64(2):257-64. PubMed ID: 24176223
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
19. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
Lacson E; Wang W; Hakim RM; Teng M; Lazarus JM
Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
[TBL] [Abstract][Full Text] [Related]
20. Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis.
Delgado C; Chertow GM; Kaysen GA; Dalrymple LS; Kornak J; Grimes B; Johansen KL
Am J Kidney Dis; 2017 Dec; 70(6):817-825. PubMed ID: 28870376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
